详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Xiaorong Dong [1] * ; Jianhua Chen [2] ; Yan Yu [3] ; Jie Hu [4] ; Xingya Li [5] ; Ying Cheng [6] ; Wenxiu Yao [7]

; Yanping Hu [8] ; Qiming Wang [9] ; Junguo Lu [10] ; Wei Zheng [11] ; Xinmin Yu [12] ; Peng Zhang [13] ; Zhuang Yu [14] ; Hongying Wei [15] ; Chuan Li [16] ; Qiqi Huang [15] ; Mengyuan Tao [16] ; Qiong Wu [16] ; Shun Lu [17] ;

机构： [1]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [2]Hunan Cancer Hospital, Changsha, China [3]Harbin Medical University Cancer Hospital, Harbin, China [4]Zhongshan Hospital, Fudan University, Shanghai, China [5]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China [6]Jilin Cancer Hospital, Changchun, Jilin, China [7]Sichuan Cancer Hospital, Chengdu, China [8]Hubei Cancer Hospital, Wuhan, China [9]Henan Cancer Hosptal, Zhengzhou, China [10]Nantong Tumor Hospital, Nantong, China [11]ShengJing Hospital of China Medical University, Shenyang, China [12]Zhejiang Cancer Hospital, Hangzhou, China [13]Shanghai Pulmonary Hospital, Shanghai, China [14]The Affiliated Hospital of Qingdao University, Qingdao, China [15]Hansoh Pharmaceutical Group Co, Ltd., Shanghai, China [16]Hansoh Pharmaceutical Group Co. Ltd., Shanghai, China [17]Shanghai Chest Hospital, Jiao Tong University, Shanghai, China

出处：

DOI：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Phase 1b study of HS-10241 combined with almonertinib in pre-treated advanced non-small cell lung cancer (NSCLC) harboring EGFR mutation

文献详情